Seoul, South Korea

Seul Gi Shin


 

Average Co-Inventor Count = 4.9

ph-index = 1


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Seul Gi Shin: Innovator in Neurodegenerative Disease Research

Introduction

Seul Gi Shin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patented inventions. With a total of 3 patents, his work focuses on monitoring protein oligomer formation, which is crucial for understanding diseases such as dementia.

Latest Patents

One of his latest patents involves a pair of amino acid sequences designed for monitoring the formation of TDP-43 oligomers in living cells via bimolecular fluorescence complementation. This patent discloses a vector pair that includes a first vector with a TDP-43 gene and a first fluorescence protein gene, along with a second vector containing a second TDP-43 gene and a second fluorescence protein gene. This innovative approach allows researchers to monitor TDP-43 oligomer formation effectively in living cells.

Another significant patent by Seul Gi Shin is related to a transgenic mouse model for dementia. This invention provides a vector pair for screening tau oligomer formation, which is essential for identifying potential inhibitors of tau oligomer formation. The transgenic model mouse developed from this research serves as a valuable tool for studying neurological diseases.

Career Highlights

Seul Gi Shin is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His work has garnered attention for its potential impact on understanding and treating neurodegenerative diseases.

Collaborations

He collaborates with notable colleagues, including Sung Su Lim and Yun Kyung Kim, who contribute to his research endeavors.

Conclusion

Seul Gi Shin's innovative work in the field of neurodegenerative diseases highlights the importance of research in understanding complex medical conditions. His patents reflect a commitment to advancing scientific knowledge and developing new methodologies for monitoring and treating these diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…